The use of a noninvasive test for liver function can accurately predict decompensation, death, or the need for liver transplantation in patients with cirrhosis, new research shows.
Predicting decompensation in patients with cirrhosis is challenged by the lack of a test that captures functional decline. Biopsy and elastography provide information about the extent of liver fibrosis, but not how well the organ is working, according to Mohammad Amin Fallahzadeh, MD, a medical resident at Baylor